Evidence map›Paper›PMID 10490632›Full record

ArticleMolecular and cellular biology1999

Cas mediates transcriptional activation of the serum response element by Src.

Y Hakak, G S Martin

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Overexpression and cytoplasmic accumulation of Hepl is associated with clinicopathological parameters and poor prognosis in non-small cell lung cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Article
  5. CAS proteins in normal and pathological cell growth control.Cellular and molecular life sciences : CMLS · 2010
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Y HakakDepartment of Molecular and Cell Biology, University of California-Berkeley, Berkeley, California 94720-3204, USA.
G S Martin
University of California, Berkeley · US

Funding

GENETICS OF RNA TUMOR VIRUSESR37CA017542 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI MARTIN, G STEVEN · 1990 to 2010
$4.0M
GENETICS OF RNA TUMOR VIRUSESR01CA017542 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI MARTIN, G STEVEN · 1985 to 2002
$1.1M
NCI NIH HHS CA17542NCI NIH HHS R01 CA017542NCI NIH HHS R37 CA017542
6 · The paper itself

Abstract

The Src substrate p130(Cas) is a docking protein containing an SH3 domain, a substrate domain that contains multiple consensus SH2 binding sites, and a Src binding region. We have examined the possibility that Cas plays a role in the transcriptional activation of immediate early genes (IEGs) by v-Src. Transcriptional activation of IEGs by v-Src occurs through distinct transcriptional control elements such as the serum response element (SRE). An SRE transcriptional reporter was used to study the ability of Cas to mediate Src-induced SRE activation. Coexpression of v-Src and Cas led to a threefold increase in SRE-dependent transcription over the level induced by v-Src alone. Cas-dependent activation of the SRE was dependent on the kinase activity of v-Src and the Src binding region of Cas. Signaling to the SRE is promoted by a serine-rich region within Cas and inhibited by the Cas SH3 domain. Cas-dependent SRE activation was accompanied by an increase in the level of active Ras and in the activity of the mitogen-activated protein kinase (MAPK) Erk2; these changes were blocked by coexpression of dominant-negative mutants of the adapter protein Grb2. SRE activation was abrogated by coexpression of dominant-negative mutants of Ras, MAPK kinase (Mek1), and Grb2. Coexpression of Cas with v-Src enhanced the association of Grb2 with the adapter protein Shc and the protein tyrosine phosphatase Shp-2; coexpression of Shc or Shp-2 mutants significantly reduced SRE activation by Cas and v-Src. Cas-induced Grb2 association with Shp-2 and Shc may account for the Cas-dependent activation of the Ras/Mek/Erk pathway and SRE-dependent transcription. 14-3-3 proteins may also play a role in Cas-mediated signaling to the SRE. Overexpression of Cas was found to modestly enhance epidermal growth factor (EGF)-induced activation of the SRE. A Cas mutant lacking the Src binding region did not potentiate the EGF response, suggesting that Cas enhances EGF signaling by binding to endogenous cellular Src or another Src family member. These observations implicate Cas as a mediator of Src-induced transcriptional activation.

Indexed as

Adaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportMAP Kinase Signaling SystemProtein Serine-Threonine KinasesResponse ElementsTranscriptional ActivationBinding SitesCrk-Associated Substrate ProteinEpidermal Growth FactorGenes, ReporterGRB2 Adaptor ProteinIntracellular Signaling Peptides and ProteinsMAP Kinase Kinase 1Mitogen-Activated Protein Kinase KinasesModels, GeneticMutationAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportCrk-Associated Substrate ProteinEpidermal Growth FactorGRB2 Adaptor ProteinIntracellular Signaling Peptides and ProteinsMAP2K1 protein, humanMAP Kinase Kinase 1Mitogen-Activated Protein Kinase KinasesOncogene Protein pp60(v-src)PhosphoproteinsProteinsProtein Serine-Threonine KinasesProtein Tyrosine Phosphatase, Non-Receptor Type 11Protein Tyrosine Phosphatase, Non-Receptor Type 6Protein Tyrosine PhosphatasesPTPN11 protein, humanPTPN6 protein, humanras ProteinsRetinoblastoma-Like Protein p130Shc Signaling Adaptor Proteins

Identifiers

PMID10490632
PMCPMC84690
OpenAlexW2151903377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.